Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aldo Scarpa

Showing results (531-540 of 574) with videos related to

Pageof 58
Sort By:
Journal of Experimental & Clinical Cancer Research : CR|December 3, 2021
Dysregulated splicing factor SF3B1 unveils a dual therapeutic vulnerability to target pancreatic cancer cells and cancer stem cells with an anti-splicing drugEmilia Alors-Perez, Ricardo Blázquez-Encinas, Sonia Alcalá, et al.
Oncotarget|September 19, 2015
Prognostic role and implications of mutation status of tumor suppressor gene ARID1A in cancer: a systematic review and meta-analysisClaudio Luchini, Nicola Veronese, Marco Solmi, et al.
Hepatology (Baltimore, Md.)|December 28, 2019
Modulation of Biliary Cancer Chemo-Resistance Through MicroRNA-Mediated Rewiring of the Expansion of CD133+ CellsPietro Carotenuto, Somaieh Hedayat, Matteo Fassan, et al.
Human Pathology|September 25, 2021
Genomic characterization of hepatoid tumors: context mattersRita T Lawlor, Andrea Mafficini, Concetta Sciammarella, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 30, 2026
A Comprehensive Assessment of the Causal Relationship Between Atopic Conditions and Pancreatic Cancer Risk: A Two-Sample Mendelian Randomization StudyJiangchuan He, Sergio Sabroso-Lasa, Claudia Coscia, et al.
Tumori|February 7, 2024
The Italian Rare Biliary tract Cancer initiative (IRaBiCa): A multicentric observational study of Gruppo Oncologico dell'Italia Meridionale (GOIM) in collaboration with Gruppo Italiano Colangiocarcinoma (GICO)Desirèe Speranza, Elena Sapuppo, Giuseppe Aprile, et al.
Journal of Hepatology|January 24, 2018
Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutationsChristopher P Wardell, Masashi Fujita, Toru Yamada, et al.
Gut|December 3, 2015
Reduced risk of pancreatic cancer associated with asthma and nasal allergiesPaulina Gomez-Rubio, Jan-Paul Zock, Marta Rava, et al.
Journal of the National Cancer Institute|December 5, 2013
Pancreatic cancer hENT1 expression and survival from gemcitabine in patients from the ESPAC-3 trialWilliam Greenhalf, Paula Ghaneh, John P Neoptolemos, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 14, 2020
Pancreatic Cancer Risk in Relation to Lifetime Smoking Patterns, Tobacco Type, and Dose-Response RelationshipsEsther Molina-Montes, Lisa Van Hoogstraten, Paulina Gomez-Rubio, et al.
Pageof 58

Showing results (531-540 of 574) with videos related to

Sort By:
Pageof 58
Journal of Experimental & Clinical Cancer Research : CR|December 3, 2021
Dysregulated splicing factor SF3B1 unveils a dual therapeutic vulnerability to target pancreatic cancer cells and cancer stem cells with an anti-splicing drugEmilia Alors-Perez, Ricardo Blázquez-Encinas, Sonia Alcalá, et al.
Oncotarget|September 19, 2015
Prognostic role and implications of mutation status of tumor suppressor gene ARID1A in cancer: a systematic review and meta-analysisClaudio Luchini, Nicola Veronese, Marco Solmi, et al.
Hepatology (Baltimore, Md.)|December 28, 2019
Modulation of Biliary Cancer Chemo-Resistance Through MicroRNA-Mediated Rewiring of the Expansion of CD133+ CellsPietro Carotenuto, Somaieh Hedayat, Matteo Fassan, et al.
Human Pathology|September 25, 2021
Genomic characterization of hepatoid tumors: context mattersRita T Lawlor, Andrea Mafficini, Concetta Sciammarella, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 30, 2026
A Comprehensive Assessment of the Causal Relationship Between Atopic Conditions and Pancreatic Cancer Risk: A Two-Sample Mendelian Randomization StudyJiangchuan He, Sergio Sabroso-Lasa, Claudia Coscia, et al.
Tumori|February 7, 2024
The Italian Rare Biliary tract Cancer initiative (IRaBiCa): A multicentric observational study of Gruppo Oncologico dell'Italia Meridionale (GOIM) in collaboration with Gruppo Italiano Colangiocarcinoma (GICO)Desirèe Speranza, Elena Sapuppo, Giuseppe Aprile, et al.
Journal of Hepatology|January 24, 2018
Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutationsChristopher P Wardell, Masashi Fujita, Toru Yamada, et al.
Gut|December 3, 2015
Reduced risk of pancreatic cancer associated with asthma and nasal allergiesPaulina Gomez-Rubio, Jan-Paul Zock, Marta Rava, et al.
Journal of the National Cancer Institute|December 5, 2013
Pancreatic cancer hENT1 expression and survival from gemcitabine in patients from the ESPAC-3 trialWilliam Greenhalf, Paula Ghaneh, John P Neoptolemos, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 14, 2020
Pancreatic Cancer Risk in Relation to Lifetime Smoking Patterns, Tobacco Type, and Dose-Response RelationshipsEsther Molina-Montes, Lisa Van Hoogstraten, Paulina Gomez-Rubio, et al.
Pageof 58